非急性前交叉韧带损伤两种管理策略(康复与手术重建)的临床与成本效果比较:ACL SNNAP随机对照试验研究方案
本研究为在英國约30个骨科单位开展的实用型多中心优效性随机对照试验,计划招募320例非急性前交叉韧带缺陷患者,1:1随机分配至非手术康复策略或手术重建策略,随访18个月,主要结局为KOOS评分,旨在比较两种策略的临床与成本效果。
要点
- 非急性ACL损伤治疗缺乏高质量证据,临床实践差异大。
- ACL SNNAP试验比较康复策略与手术重建策略的临床与成本效果。
- 主要结局为18个月时KOOS评分,计划招募320例患者。
核心结论
- 该试验旨在确定非急性前交叉韧带缺陷患者中,非手术康复策略(必要时可后续重建)是否比直接手术重建策略更具临床效果和成本效果。
研究设计与样本
- 实用型、多中心、优效性、随机对照试验,两臂平行分组,1:1分配。
- 计划从英国约30个二级骨科单位招募320例有症状的非急性前交叉韧带缺陷患者。
- 通过基于网络的随机化系统进行随机分组,因干预性质无法对患者和临床医生设盲。
- 通过自报问卷在6、12和18个月进行随访。
关键数值与推荐
- 主要结局为随机化后18个月时的膝关节损伤和骨关节炎结局评分(KOOS)。
- 次要结局包括恢复运动/活动、干预相关并发症、患者满意度、活动期望、通用健康生活质量、膝关节特异性生活质量和资源使用。
临床怎么用
- 该试验结果将为非急性ACL缺陷的治疗选择提供临床与成本效果证据,并可能影响未来护理标准。
局限性
- 因干预性质无法对患者和临床医生设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anterior cruciate ligament (ACL) rupture is a common knee injury that can lead to poor quality of life, decreased activity and increased risk of secondary osteoarthritis of the knee. Management of patients with a non-acute ACL injury can include a non-surgical (rehabilitation) or surgical (reconstruction) approach. However, insufficient evidence to guide treatment selection has led to high variation in treatment choice for patients with non-acute presentation of ACL injury. The objective of the ACL SNNAP trial is to determine in patients with non-acute anterior cruciate ligament deficiency (ACLD) whether a strategy of non-surgical management (rehabilitation) (with option for later ACL reconstruction only if required) is more clinically effective and cost effective than a strategy of surgical management (reconstruction) without prior rehabilitation with all patients followed up at 18 months. METHODS: The study is a pragmatic, multi-centre, superiority, randomised controlled trial with two-arm parallel groups and 1:1 allocation. Patients with a symptomatic non-acute ACL deficient knee will be randomised to either non-surgical management (rehabilitation) or surgical management (reconstruction). We aim to recruit 320 patients from approximately 30 secondary care orthopaedic units from across the United Kingdom. Randomisation will occur using a web-based randomisation system. Blinding of patients and clinicians to treatment allocation will not be possible because of the nature of the interventions. Participants will be followed up via self-reported questionnaires at 6, 12 and 18 months. The primary outcome is the Knee injury and Osteoarthritis Outcome Score (KOOS) at 18 months post randomisation. Secondary outcomes will include a return to sport/activity, intervention-related complications, patient satisfaction, expectations of activity, generic health quality of life, knee specific quality of life and resource usage. DISCUSSION: At present, no evidence-based treatment of non-acute ACL deficiency exists, particularly in the NHS. Moreover, little consensus exists on the management approach for these patients. The proposed trial will address this gap in knowledge regarding the clinical and cost effectiveness of ACL treatment and inform future standards of care for this condition. TRIAL REGISTRATION: ISRCTN: 10110685. Registered on 16 November 2016. ClinicalTrials.gov: NCT02980367. Registered in December 2016.
引用
- Davies L, Cook J, Leal J, et al. Comparison of the clinical and cost effectiveness of two management strategies (rehabilitation versus surgical reconstruction) for non-acute anterior cruciate ligament (ACL) injury: study protocol for the ACL SNNAP randomised controlled trial. Trials. 2020. PMID: 32410697. doi:10.1186/s13063-020-04298-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。